Donate to save lives this Breast Cancer Awareness Month.
The purpose of this study to test cryotherapy (cold therapy) for preventing chemotherapy induced peripheral neuropathy (CIPN) in patients receiving taxane chemotherapy for treatment of cancer.
Compare the severity of patient reported neuropathy symptoms using the European Organization for Research and Treatment of Cancer (EORTC-QLQ-CIPN20) quality of life (QOL) questionnaire at baseline, at the completion of taxane chemotherapy, and 6 months following completion of taxane chemotherapy between cryotherapy treated patients and controls.
Who is it for?
You may be eligible for this study if you are aged 18 or over and are receiving taxane therapy for breast or gynaecological cancer.
All participants in this study will continue receiving their chemotherapy as per the standard protocol. Two groups will be formed by random chance. One group will receive cryotherapy delivered by Ice Replacement pads (IRP) wrapped around both hands and feet. These pads will be changed every 30 minutes from 15 minutes before chemotherapy until 15 minutes after chemotherapy. The other group will have their chemotherapy without any cryotherapy.
All participants will answer questionnaires about their quality of life and any side-effects at the beginning of the study, at the end of chemotherapy and six months after completion of chemotherapy.
It is hoped this research will improve patient quality of life by demonstrating cryotherapy helps reduce CIPN, which is a potentially debilitating side effect of chemotherapy.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at firstname.lastname@example.org
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to email@example.com